MyETF.app
HomeUS Marketequity › FBT

FBT — First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund (ticker: FBT) is a equity ETF issued by First Trust tracking NYSE Arca Biotechnology Index. It was launched on 2006-06-19.

Live Price$225.785
Change2.10%
AUM$2.48B
Expense Ratio0.01%
Avg Volume69,555.8

Returns (Total Return)

PeriodReturn
1 Day2.92%
1 Week2.75%
1 Month7.58%
3 Months9.94%
6 Months3.95%
YTD7.08%
1 Year35.94%
3 Years42.00%
5 Years39.85%
10 Years
Since Inception

Top Holdings

#SecuritySymbolWeight
1 Moderna, Inc. MRNA 5.74%
2 Moderna, Inc. MRNA 5.74%
3 Moderna, Inc. MRNA 5.74%
4 Moderna, Inc. MRNA 5.74%
5 Moderna, Inc. MRNA 5.74%
6 Moderna, Inc. MRNA 5.74%
7 BeiGene, Ltd. (ADR) ONC 5.25%
8 BeiGene, Ltd. (ADR) ONC 5.25%
9 BeiGene, Ltd. (ADR) ONC 5.25%
10 BeiGene, Ltd. (ADR) ONC 5.25%

Fund Profile

IssuerFirst Trust
BrandFirst Trust
Asset Classequity
StrategyEqual
StructureETF
CategoryHealth & Biotech Equities
SegmentEquity: U.S. Biotechnology
SectorBiotechnology
RegionNorth America
Index TrackedNYSE Arca Biotechnology Index
Inception Date2006-06-19
Tax on DistributionsQualified dividends

Quick Facts

TickerFBT
Full NameFirst Trust NYSE Arca Biotechnology Index Fund
IssuerFirst Trust
Asset Classequity
Expense Ratio0.01%
AUM$2.48B
Inception2006-06-19
Index TrackedNYSE Arca Biotechnology Index

Frequently Asked Questions

What does FBT track?

FBT (First Trust NYSE Arca Biotechnology Index Fund) tracks NYSE Arca Biotechnology Index, a equity benchmark.

What is the expense ratio of FBT?

FBT has an expense ratio of 0.01% per year.

What is the AUM of FBT?

FBT has approximately $2.48B in assets under management.

Does FBT pay a dividend?

FBT distributes income according to its prospectus (Qualified dividends tax treatment). Check the dividend history tab for ex-dividend dates and yield.

Who issues FBT?

FBT is issued by First Trust, launched on 2006-06-19.

Open the interactive FBT dashboard for charts, historical fund flows, holdings breakdown and seasonality patterns.